The results showed that in addition to inducing activity in familiar pathways, the drugs also triggered the central amygdala, a region associated with desire that is deeper in the brain than scientists previously thought GLP-1s could directly reach
Some had hoped that its efficacy would more closely resemble that of existing injections on the market which can result in up to a 20% body weight loss while others noted the trial drop-out rate of 12% due to side effects or personal reasons
[16] [17] These studies, involving tens of thousands of patients, have found no significant association between GLP-1 receptor agonist use and increased cancer incidence overall, including breast cancer specifically
GLP-1 medications such as semaglutide (Ozempic) and tirzepatide (Mounjaro) are powerful tools for weight loss
But the real-world data tells a different story smaller weight loss, higher costs, and uncertain long-term outcomes
Some forward-looking physicians and medical practitioners are now using peptides as a way to reverse the cellular clock in your body and enable it to function like it used to when you were younger